Primary Record
GADOTERIDOL
Note: Only for scientific research or as raw materials for production.
- In stock
- 2,914 g
- Purity
- 99.6 %
- CAS
- 120066-54-8
Compound Identifiers & Properties
- CAS
- 120066-54-8
- PubChem CID
- 60714
- SMILES
- CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]
- Canonical SMILES
- CC(O)CN1CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC1.[Gd+3]
Names & Synonyms
- GADOTERIDOL
- ProHance
- Gadoteridolum
- Prohance Multipack
- Gadolinium-HP-DO3A
- Prohance (TN)
- 120066-54-8
- Gadolinium-HP-Do 3A
- GD-HP-DO 3A
- Gd-HPDO3A
- gadolinium HP-DO3A
- GdHPDO3A
- Gd-HP-DO3A
- Gadolinium-HP-D03A
- H-D-Ile-Asp-OH
- Gd-hydroxypropyl-D03A
- RefChem:56478
- GADOTERIDOL [MI]
- GADOTERIDOL [INN]
- GADOTERIDOL [JAN]
- Gd(DO3A)
- Gd(HP-DO3A)
- C17H29GdN4O7
- DTXSID2048662
- GADOTERIDOL [HSDB]
- GADOTERIDOL [USAN]
- D0M1PL
- Gd-HP-D03A
- GADOTERIDOL [VANDF]
- Gadoteridolum [INN-Latin]
- AC1L1TS2
- GADOTERIDOL [MART.]
- DTXCID5028588
- GADOTERIDOL [USP-RS]
- GADOTERIDOL [WHO-DD]
- HSDB 7549
- Gadoteridol (JAN/USP/INN)
- DPNNNPAKRZOSMO-UHFFFAOYSA-K
- SCHEMBL1650466
- SQ-32692
- UNII-0199MV609F
- CHEBI:31643
- GADOTERIDOL [ORANGE BOOK]
- V08CA04
- GADOTERIDOL [USP IMPURITY]
- HMS3264D11
- HMS5087L05
- MOLI001032
- 0199MV609F
- C17-H29-Gd-N4-O7
- GADOTERIDOL [USP MONOGRAPH]
- NSC-760055
- BCP13402
- CID60714
- Gadoteridol [USAN:BAN:INN:JAN]
- Gadoteridol [USAN:INN:BAN:JAN]
- Tox21_113025
- Tox21_113128
- EBC-27320
- SQ 32692
- Tox21_113025_1
- ACN-043393
- CCG-213206
- DB00597
- SQ 32,692
- Gadoteridol [USAN:USP:INN:BAN:JAN]
- NCGC00182068-02
- NCGC00182068-03
- NCGC00182068-04
- BC678010
- CAS-120066-54-8
- E0006
- NS00078663
- D01137
- F85197
- A996213
- Q5516429
- 2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
- (+-)-(10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))gadolinium
- (10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato)gadolinium
- Gadolinium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane
- gadolinium 2,2',2''-[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate
- gadolinium 1,4,7-tris(carboxymethyl)-10-(2'-hydroxypropyl)-1,4,7,10-tetraazacyclododecane
- (+/-)-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATO(3-))GADOLINIUM.
- [10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7,O10]gadolinium
- 1,4,7,10-Tetraazacyclododecan-1,4,7-triacetic acid, 10-(2-hydroxypropyl)-, gadolinium complex
- 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid gadolinium complex
- 112188-16-6
- 120067-35-8
- gadolinium 2,2',2''-(10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
- gadolinium(3+) 2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate
- gadolinium(3+) ion 2-(4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetate
- gadolinium(3+); 2-[4-(2-hydroxypropyl)-7,10-bis(2-oxido-2-oxoethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate
- gadolinium(III) 2,2',2''-(10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
- Gadolinium, (1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7)-
- Gadolinium, (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N(sup 1),N(sup 4),N(sup 7),N(sup 10),O(sup 1),O(sup 4),O(sup 7),O(sup 10))-
- GADOLINIUM, (10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATO(3-)-N1,N4,N7,N10,O1,O4,O7,O10)-
- SQ-32692; SQ 32692; SQ32692; Gd-HP-DO3A; GD-HP-DO 3A;Gd-HPDO3A;Gd-hydroxypropyl-D03A